Cargando…

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

Extracellular vesicles (EVs) are membrane-bound particles involved in intercellular communication. They carry proteins, lipids, and nucleotides such as microRNAs (miRNAs) from the secreting cell that can modulate target cells. We and others have previously described the presence of EVs in peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sáenz-Cuesta, Matías, Alberro, Ainhoa, Muñoz-Culla, Maider, Osorio-Querejeta, Iñaki, Fernandez-Mercado, Marta, Lopetegui, Itziar, Tainta, Mikel, Prada, Álvaro, Castillo-Triviño, Tamara, Falcón-Pérez, Juan Manuel, Olascoaga, Javier, Otaegui, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121302/ https://www.ncbi.nlm.nih.gov/pubmed/30126230 http://dx.doi.org/10.3390/ijms19082448

Ejemplares similares

Therapeutic Potential of Extracellular Vesicles for Demyelinating Diseases; Challenges and Opportunities
por: Osorio-Querejeta, Iñaki, et al.
Publicado: (2018)

Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA – mRNA network analysis
por: Irizar, Haritz, et al.
Publicado: (2015)

SncRNA (microRNA & snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent
por: Muñoz-Culla, Maider, et al.
Publicado: (2016)

T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians
por: Alberro, Ainhoa, et al.
Publicado: (2019)

Methods for Extracellular Vesicles Isolation in a Hospital Setting
por: Sáenz-Cuesta, Matías, et al.
Publicado: (2015)

Progressive changes in non-coding RNA profile in leucocytes with age
por: Muñoz-Culla, Maider, et al.
Publicado: (2017)

Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls
por: Iparraguirre, Leire, et al.
Publicado: (2021)

Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
por: Sáenz-Cuesta, Matías, et al.
Publicado: (2014)

Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation
por: Alberro, Ainhoa, et al.
Publicado: (2016)

Transcriptomic Profile Reveals Gender-Specific Molecular Mechanisms Driving Multiple Sclerosis Progression
por: Irizar, Haritz, et al.
Publicado: (2014)

O group is a protective factor for COVID19 in Basque population
por: Muñoz-Culla, Maider, et al.
Publicado: (2021)

Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals
por: Iparraguirre, Leire, et al.
Publicado: (2023)

Inflammaging markers characteristic of advanced age show similar levels with frailty and dependency
por: Alberro, Ainhoa, et al.
Publicado: (2021)

Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis
por: Moles, Laura, et al.
Publicado: (2022)

ABO blood group distributions in multiple sclerosis patients from Basque Country; O(-) as a protective factor
por: Lopetegi, Itziar, et al.
Publicado: (2019)

MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles
por: Osorio-Querejeta, Iñaki, et al.
Publicado: (2020)

Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease
por: Iparraguirre, Leire, et al.
Publicado: (2020)

Extracellular Vesicles in Blood: Sources, Effects, and Applications
por: Alberro, Ainhoa, et al.
Publicado: (2021)

The genetics of multiple sclerosis: review of current and emerging candidates
por: Muñoz-Culla, Maider, et al.
Publicado: (2013)

Editorial: Novel Clinical Applications of Extracellular Vesicles
por: Sáenz-Cuesta, Matías, et al.
Publicado: (2015)

Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models
por: Álvarez-Satta, María, et al.
Publicado: (2020)

Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients
por: Otaegui, David, et al.
Publicado: (2009)

Assessing the Potential of Molecular Imaging for Myelin Quantification in Organotypic Cultures
por: Egimendia, Ander, et al.
Publicado: (2021)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
por: Camacho-Toledano, Celia, et al.
Publicado: (2022)

Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old
por: Fernández-Eulate, Gorka, et al.
Publicado: (2018)

Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection
por: Aragon, Larraitz, et al.
Publicado: (2023)

Early biochemical analysis of COVID-19 patients helps severity prediction
por: Roncancio-Clavijo, Andrés, et al.
Publicado: (2023)

Expression Profiling Analysis Reveals Key MicroRNA–mRNA Interactions in Early Retinal Degeneration in Retinitis Pigmentosa
por: Anasagasti, Ander, et al.
Publicado: (2018)

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
por: Mar, Javier, et al.
Publicado: (2019)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Antidepressant activity of fingolimod in mice
por: di Nuzzo, Luigi, et al.
Publicado: (2015)

Fingolimod for Irradiation-Induced Neurodegeneration
por: Metzdorf, Judith, et al.
Publicado: (2019)

Electrochemical Activity of Lignin Based Composite Membranes
por: Baloch, Marya, et al.
Publicado: (2021)

Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
por: Meca-Lallana, J. E., et al.
Publicado: (2021)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017)

Fingolimod—A Sphingosine-Like Molecule Inhibits Vesicle Mobility and Secretion in Astrocytes
por: Trkov, Saša, et al.
Publicado: (2012)

Intermittent Atrioventricular Block following Fingolimod Initiation
por: Gialafos, E., et al.
Publicado: (2014)

Vagomimetic Effects of Fingolimod: Physiology and Clinical Implications
por: Vanoli, Emilio, et al.
Publicado: (2014)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7cdtuli55b9nme1fvh3iv88v0j